Reaction Details |
| Report a problem with these data |
Target | Transient receptor potential cation channel subfamily V member 1 |
---|
Ligand | BDBM20564 |
---|
Substrate/Competitor | BDBM10852 |
---|
Meas. Tech. | Capsaicin Antagonist Assay |
---|
pH | 7.4±n/a |
---|
Temperature | 295.15±n/a K |
---|
IC50 | >4000±n/a nM |
---|
Comments | Thermodynamic solubility = 32 ug/mL in 0.01 N HCl, measured in a high-throughput automated format. |
---|
Citation | Wang, HL; Katon, J; Balan, C; Bannon, AW; Bernard, C; Doherty, EM; Dominguez, C; Gavva, NR; Gore, V; Ma, V; Nishimura, N; Surapaneni, S; Tang, P; Tamir, R; Thiel, O; Treanor, JJ; Norman, MH Novel vanilloid receptor-1 antagonists: 3. The identification of a second-generation clinical candidate with improved physicochemical and pharmacokinetic properties. J Med Chem50:3528-39 (2007) [PubMed] Article |
---|
More Info.: | Get all data from this article, Solution Info, Assay Method |
---|
|
Transient receptor potential cation channel subfamily V member 1 |
---|
Name: | Transient receptor potential cation channel subfamily V member 1 |
Synonyms: | Capsaicin receptor | OTRPC1 | TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 (TRPV1) | Trpv1 | Vanilloid Receptor 1 (TRPV1, VR1) | Vanilloid VR1 | Vanilloid receptor | Vanilloid receptor 1 (VRI/TRPV1) | Vanilloid receptor type 1-like | Vanilloid receptor type 1-like (TrpV1/Vr1) | Vr1 | Vr1l | osm-9-like TRP channel 1 |
Type: | Transient Receptor |
Mol. Mass.: | 94956.12 |
Organism: | Rattus norvegicus (rat) |
Description: | O35433 |
Residue: | 838 |
Sequence: | MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASP
LDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDA
VAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVA
RKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTK
GRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVD
NTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEP
ECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNR
LLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEIL
SVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVAS
MVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIE
DGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFI
ILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAF
RSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSG
RVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK
|
|
|
BDBM20564 |
---|
BDBM10852 |
---|
Name | BDBM20564 |
Synonyms: | N-(4-{[6-(morpholin-4-yl)pyrimidin-4-yl]oxy}-1,3-benzothiazol-2-yl)acetamide | Piperazinylpyrimidine analogue, 15 |
Type | Small organic molecule |
Emp. Form. | C17H17N5O3S |
Mol. Mass. | 371.414 |
SMILES | CC(=O)Nc1nc2c(Oc3cc(ncn3)N3CCOCC3)cccc2s1 |
Structure |
|